UCL and Roche Study Finds Smartphone Tests Could Improve Tracking of Huntington’s Disease Progression

Researchers at University College London (UCL) and Roche have identified smartphone-based digital tests as a potential tool for improving the detection of disease progression in Huntington’s disease. The study suggests that these tests, conducted through a smartphone app, could streamline clinical trials and enhance their efficiency.

The findings indicate that the use of digital assessments may provide more precise measurements of how Huntington’s disease progresses over time. This approach could help researchers better understand the condition and evaluate the effectiveness of treatments during clinical trials. The study highlights the potential for technology to play a significant role in advancing drug development efforts for neurodegenerative diseases like Huntington’s.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: June 9, 2025

Related posts:

Generic Drug Market Poised for Growth: Over 200 Brand-Name Drugs to Lose Patent Protection by 2027. Eli Lilly Sues Telehealth Companies Alleging Unlicensed Practice of Medicine Through Diagnosis and Prescription Services Zealand Pharma Submits MAA for Twice-Weekly Glepaglutide to Treat Short Bowel Syndrome Roche Reports BTK Inhibitor Suppresses Disability Progression in RMS Patients for Two Years

Author

Mark Chiang